|Articles|July 1, 2001

The American Journal of Managed Care

  • July 2001
  • Volume 7
  • Issue 7

Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States

Download PDF: Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States

Articles in this issue

over 24 years ago

Electronic Prescribing in Ambulatory Practice: Promises, Pitfalls, and Potential Solutions

over 24 years ago

Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts

over 24 years ago

Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans

over 24 years ago

Promoting Smoking Abstinence in Pregnant and Postpartum Patients: A Comparison of Two Approaches

over 24 years ago

Primary Care Physician Job Satisfaction and Turnover

over 24 years ago

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text